Omnicell, Inc. OC9.F Stock
Omnicell, Inc. Price Chart
Omnicell, Inc. OC9.F Financial and Trading Overview
Omnicell, Inc. stock price | 29.6 EUR |
Previous Close | 66 EUR |
Open | 65.5 EUR |
Bid | 65.5 EUR x 10100 |
Ask | 66 EUR x 10000 |
Day's Range | 65.5 - 65.5 EUR |
52 Week Range | 43.2 - 116 EUR |
Volume | 10 EUR |
Avg. Volume | 0 EUR |
Market Cap | 2.99B EUR |
Beta (5Y Monthly) | 0.891901 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.42 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 167.5 EUR |
OC9.F Valuation Measures
Enterprise Value | 3.25B EUR |
Trailing P/E | N/A |
Forward P/E | 15.898059 |
PEG Ratio (5 yr expected) | 2.85 |
Price/Sales (ttm) | 2.362328 |
Price/Book (mrq) | 2.5837245 |
Enterprise Value/Revenue | 2.564 |
Enterprise Value/EBITDA | 72.604 |
Trading Information
Omnicell, Inc. Stock Price History
Beta (5Y Monthly) | 0.891901 |
52-Week Change | -35.92% |
S&P500 52-Week Change | 20.43% |
52 Week High | 116 EUR |
52 Week Low | 43.2 EUR |
50-Day Moving Average | 59.69 EUR |
200-Day Moving Average | 61.42 EUR |
OC9.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 1 EUR |
Shares Outstanding | 45.08M |
Float | 44.32M |
Short Ratio | N/A |
% Held by Insiders | 1.38% |
% Held by Institutions | 102.80% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -1.38% |
Operating Margin (ttm) | -1.050% |
Gross Margin | 45.09% |
EBITDA Margin | 3.53% |
Management Effectiveness
Return on Assets (ttm) | -0.38% |
Return on Equity (ttm) | -1.58% |
Income Statement
Revenue (ttm) | 1.27B EUR |
Revenue Per Share (ttm) | 28.45 EUR |
Quarterly Revenue Growth (yoy) | -8.79% |
Gross Profit (ttm) | 596.71M EUR |
EBITDA | 44.76M EUR |
Net Income Avi to Common (ttm) | -17565000 EUR |
Diluted EPS (ttm) | -0.36 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 340.41M EUR |
Total Cash Per Share (mrq) | 7.55 EUR |
Total Debt (mrq) | 615.07M EUR |
Total Debt/Equity (mrq) | 53.83 EUR |
Current Ratio (mrq) | 2.06 |
Book Value Per Share (mrq) | 25.351 |
Cash Flow Statement
Operating Cash Flow (ttm) | 106.55M EUR |
Levered Free Cash Flow (ttm) | 82.54M EUR |
Profile of Omnicell, Inc.
Country | Germany |
State | CA |
City | Santa Clara |
Address | 2625 Augustine Drive |
ZIP | 95054 |
Phone | 650 251 6100 |
Website | https://www.omnicell.com |
Industry | Health Information Services |
Sector(s) | Healthcare |
Full Time Employees | 3830 |
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Santa Clara, California.
Q&A For Omnicell, Inc. Stock
What is a current OC9.F stock price?
Omnicell, Inc. OC9.F stock price today per share is 29.6 EUR.
How to purchase Omnicell, Inc. stock?
You can buy OC9.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Omnicell, Inc.?
The stock symbol or ticker of Omnicell, Inc. is OC9.F.
Which industry does the Omnicell, Inc. company belong to?
The Omnicell, Inc. industry is Health Information Services.
How many shares does Omnicell, Inc. have in circulation?
The max supply of Omnicell, Inc. shares is 46.3M.
What is Omnicell, Inc. Price to Earnings Ratio (PE Ratio)?
Omnicell, Inc. PE Ratio is now.
What was Omnicell, Inc. earnings per share over the trailing 12 months (TTM)?
Omnicell, Inc. EPS is -0.42 EUR over the trailing 12 months.
Which sector does the Omnicell, Inc. company belong to?
The Omnicell, Inc. sector is Healthcare.